Tombazzi - Carcinoid, GIST, Lymphoma Flashcards

1
Q

What are the basic features of carcinoid tumors?

A
  • Late middle-aged pts
  • Most in GI tract: 40% in small intestine (also in the lungs and tracheobronchial tree)
    1. Often at multiple sites in the GI tract: can be found anywhere b/t stomach and rectum
  • Make molecules w/effects in other parts of the body, most commonly: histamine or serotonin
  • CLINICAL PRESENTATION: often asymptomatic, but may present with abdominal pain if tumor is big enough (via intermittent obstruction, which can also cause bleeding and/or anemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 3 types of carcinoid found in the stomach?

A
  • 80% type 1 or type 2: found in body of the stomach (b/c this is where NE/parietal cells are), generally multiple, very small most of the time, and grow in high levels of gastrin -> difference b/t these 2 is that gastrin is coming from different areas
    1. T1: assoc w/hyper-gastrinemia in antrum; good prognosis
    2. T2: assoc w/gastrinoma outside the stomach; some w/metastasis
  • T3 (20%): not assoc w/hyper-gastrinemia, and many with mets at diagnosis -> AGGRESSIVE
  • NOTE: malignant tumors that often behave in a much more benign way than adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some of the things gastric carcinoid may be associated with?

A
  • Endocrine cell hyperplasia
  • Autoimmune chronic atrophic gastritis
  • MEN-I
  • Zollinger-Ellison syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most frequent cancer in the GI tract?

A

Adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

71-yo WM presents w/epigastric pain and anemia. Endoscopy shows >10 nodules (7-12mm) in body and fundus of stomach. Biopsy shown. What is going on?

A
  • Type I neuroendocrine/carcinoid tumor: biopsy shows aggregates of neuroendocrine cells
  • Multiple, benign, located in body and fundus (more parietal (NE) cells), will show improvement after reducing gastrin by antrectomy
  • HISTO: islands of small, round cells with salt and pepper chromatin
  • NOTE: all low-grade NE tumors look the same, no matter where they come from
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the most important prognostic factor for GI carcinoid tumors?

A
  • LOCATION
  • Foregut: stomach, duodenum prox to ligament of Treitz, and esophagus, rarely metastasize and are generally cured by resection
    1. Particularly true for gastric carcinoid tumors that arise in association with atrophic gastritis
  • Midgut: jejunum and ileum are often multiple and tend to be aggressive
  • Hindgut: appendix and colorectum are typically discovered incidentally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some standard txs for removal of hindgut NE/carcinoid tumors?

A
  • Most comm neoplasm in appendix: can tx with appendectomy, unless large (>1cm)
  • Small rectal nodules (<1cm) can be removed endoscopically with the same rubber band used for esophageal banding (see attached image)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the pathophysiology of carcinoid tumors?

A

Chronic gastritis OR gastric acid suppression

leads to

Hyper-gastrinemia compensatory response

leads to

Gastric diffuse neuroendocrine hyperplasia

leads to

Gastric carcinoid tumors

  • Any clinical situation w/high gastrin puts pt at risk, i.e., chronic H. pylori infection (can develop atrophic gastropathy)
  • PPI’s do NOT INC risk according to current data in humans (in animals, yes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do you see here? Describe the disease and the histo.

A
  • Auto-immune gastritis: Ab’s to parietal cells (H/K ATPase or intrinsic factor) in body of the stomach that lead to DEC acid production and INC gastrin
  • SEQUELAE: atrophy, pernicious anemia, carcinoid tumor, adenocarcinoma
  • ASSOCIATIONS: autoimmune disease -> thyroiditis, diabetes mellitus, Graves disease
  • HISTO: lymphos (inflammation) + gland atrophy + intestinal metaplasia + NE hyperplasia
    1. Sometimes see little islands in background, but best to stain: synaptophysin/chromogranin show a lot more than you can see on H&E
    2. Atrophic gastritis w/NE hyperplasia (in patho)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

71-yo WM presents w/epigastric pain and anemia. Endoscopy shows >10 nodules (7-12mm) in body and fundus of stomach. Biopsy shows carcinoid tumors. Tx?

A
  • Antrectomy: can get malabsorption of Vit. B12, iron, and Vit. C in some pts., but they can live w/o significant problems
  • So many nodules in this pt, they can’t be removed with scope -> have to remove gastrin, and nodules will go away
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is this? Utility?

A
  • Endoscopic ultrasound: can be used to see how deep tumors go into wall of the stomach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

60-yo WM presents w/new onset of iron deficiency anemia and 4-mo hx of diarrhea and abdominal pain. Frequent episodes of cutaneous flushing+ feeling that he is about to pass out. Abdominal CT and upper endoscopy of pancreas attached.

What is going on? What additional studies might you do?

A
  • Type 2 neuroendocrine/carcinoid tumor: primary tumor outside of the stomach + high gastrin level due to associated gastrinoma
    1. See attached image of small nodules in stomach detected via upper endoscopy
  • CT: white spots = hyper-dense lesions -> NE tumors are 1 of the few cancers that are hyper-dense
  • EUS: hyper-echoic, rounded lesion sitting at head of the pancreas
  • ADDITIONAL STUDIES: 5-HIAA, chromogranin, serum gastrin, Octreotide scan, biopsy of liver lesion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is this?

A
  • Octreotide scan with SPECT (single-photon emission computed tomography): shows where tumors are
  • Located in 2 different areas here: mass near pancreatic head and multiple lesions within the liver c/w neuroendocrine tumor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What do you see here? What hormone might you stain this for?

A
  • Neuroendocrine tumor from liver biopsy: nests, trabeculae and gland-like arrangements of mid-size cells
  • Small round nuclei and moderate basophilic cytoplasm
  • No normal liver here
  • (+) immunostain for gastrin attached: hormone expression NOT sufficienctly specific to assign origin of metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What immunostains would be positive in a NE tumor?

A
  • Chromogranin
  • Synaptophysin
  • CD56
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical features of carcinoid syndrome? Dx? Tx?

A
  • 10% of pts w/carcinoid tumors: typically ileal tumors w/liver mets -> bioactive products can be released directly into systemic circulation
  • Episodes of cutaneous flushing, sweating, diarrhea, bronchospasm, and colicky abdominal pain
    1. Due to vasoactive polypeptides, SEROTONIN
  • R heart endocardial/valvular fibrosis (50%): these substances disappear in lung, so no problems L heart
  • Also can be overcome with large tumor burden and hormones secreted into non-portal circulation
  • DX: high urine 5-hydroxyindole acetic acid (5-HIAA), a metabolic product of serotonin; limited sensitivity and specificity
  • TX: Octreotide injections once per week
  • NOTE: may be an exam question on this…
17
Q

What is the clinical presentation of Z-E? Diagnosis?

A
  • CLINICAL PRESENTATION: complicated peptic ulcer disease, diarrhea, abdominal pain, weight loss, other
    1. Diarrhea b/c extra acid in small intestine from stomach, inactivating pancreatic enzymes
    2. Risk for devo of T2 gastric carcinoma
  • DIAGNOSIS:
    1. Fasting gastrin >1000 pg/ml + gastric pH <5
    2. Secretin stimulation test: gastrin levels 0, 2, 5, 10, 15 & 20 min after IV Secretin -> INC in gastrin of >200 pg/ml (“normally” a DEC in gastrin)
    a. Sensitivity 83%, specificity 100%
18
Q

What are the treatments for Z-E syndrome?

A
  • SURGICAL RESECTION: if solitary, non-metastatic
  • MEDICAL MGMT: all should receive high-dose PPI
    1. Long-acting somatostatin analog (Sandostatin)
    2. Metastatic disease: streptozocin/doxorubicin or temozolomide
    a. Resection, orthotopic liver transplant (OLT) trans-arterial chemo-embolization (TACE), radiofrequency ablation (RFA)
19
Q

What do you see here?

A
  • Ménétrier disease: hypertrophic gastropathy
  • Characterized by irregular enlargement of gastric rugae in body and fundus
    1. MICRO: sheet of polypoid structures
  • Antrum generally spared
  • Unknown cause: may be precipitated by infection
20
Q

What is going on here?

A
  • Z-E syndrome: doubling of oxyntic mucosal thickness due to a five-fold INC in # of parietal cells
21
Q

Based on this endoscopic presentation (submucosal lesion) what is the least likely diagnosis?

A
  • Adenocarcinoma
  • Comes from the mucosa -> you would expect changes in the mucosa
22
Q

What is a GIST? Clinical presentation? Prognosis?

A
  • Most frequent sub-mucosal tumor in stomach
  • Neoplasms of spindle, epithelioid, or pleomorphic mesenchymal cells, and often express KIT (CD117)
    1. Neoplastic transformation of pluripotent mesenchymal cells in G.I. tract. formerly labeled leiomyomas and neurofibromas, among others
  • CLINICAL PRESENTATION: from asymptomatic (benign) to very aggressive
    1. More common manifestations: incidental finding, GI bleeding, abdominal mass or pain
  • PROGNOSIS: behaves depending on size and histo (biopsy)
23
Q

What are 2 causes of hypertrophic gastropathy?

A
  • Ménétrier disease
  • Zollinger-Ellison Syndrome
24
Q

55-yo M w/heartburn for 8 yrs. Normal appetite, no weight loss. PE = normal. Upper endoscopy attached.

What is going on? Why? What next?

A
  • GIST: smooth nodules covered in normal-appearing mucosa
  • EUS/FNA (biopsy): tumor coming from muscularis propria (interstitial cells of Cajal)
25
Q

65-yo M presents w/hx of black stools for 5d. Weak. Normal appetite, and no weight loss. PE = melena. Hb: 7g/dl, Hct: 21%. Upper endoscopy attached.

What is going on? Tx?

A
  • GIST with active bleeding: very low hemoglobin + active bleeding from tumor on endoscopy
  • Normal-appearing mucosa covering the tumor
  • This is an emergency
  • TX: coat tumor in epinephrine to stop bleeding, and remove (surgery)
26
Q

69-yo presents w/DOE. PE = epigastric mass. Hct: 30.7%. Large, ulcerated gastric mass measuring 23 x 13 x 20 cm. No LAD.

What is going on? Why does he have DOE?

A
  • Big, aggressive GIST: unresectable (attached), and he had tumor embolism and died
  • DOE: anyone with baseline CV disease and anemia will not have enough red cells to supply body with O2
27
Q

This is a GIST. What stain is this? Characteristic histo?

A
  • C-kit stain: 75-80% of GIST’s have oncogenic, GOF mutations in the receptor tyrosine kinase KIT (=CD117)
    1. Newer/better stain = DOG-1 (more specific)
  • Spindle-cell (or epithelioid) lesion of the GI tract (see image)
  • Most common mesenchymal tumor of the abdomen, and >50% occur in the stomach
  • From interstitial cells of Cajal, or pacemaker cells, of the GI muscularis propria
28
Q

How might you distinguish a GIST from a leiomyosarcoma?

A
  • Leiomyosarcoma much more pleomorphic, and will NOT stain (+) for C-kit (CD117) -> see attached images
29
Q

What is the Carney triad?

A
  • Non-hereditary syndrome of unknown etiology seen primarily in young females that includes:
    1. Gastric GIST,
    2. Paraganglioma (pheos not in the adrenal; Zellballen appearance*), and
    3. Pulmonary chondroma
  • INC incidence of GIST in pts w/neurofibromatosis T1
  • *Nest-like clusters of uniform, round-to-polygonal chief cells surrounded by delicate, richly vascular tissue and sustentacular cells
30
Q

How are GIST’s diagnosed and treated?

A
  • DX: endoscopy shows a submucosal lesion
    1. Endoscopic US-guided FNA has 82% sensitivity and 100% specificity
  • TX: surgery
    1. If metastatic, can usually be given tyrosine kinase inhibitor, Imatinib mesylate
31
Q

How do GI lymphomas present? Most common?

A
  • More frequent in stomach and small bowel, but infrequent overall
  • Almost all are Non-Hodgkin lymphoma, and most are B-cell (MALT and diffuse large B-cell most comm in the US)
    1. 2o involvement common: 10% in limited and 60% in advanced NHL
  • Most PRESENT similar to adenocarcinoma: epigastric pain > anorexia > weight loss > N/V > GI bleeding > early satiety
    2. 12% have Systemic B symptoms: weight loss, fever, and night sweats
32
Q

What are the 5 GI lymphomas we need to know (and their associations)?

A
  • Extra-nodal marginal zone lymphoma of mucosa-associated lymphoproliferative tissue (MALT): assoc w/H. pylori (can cure with AB’s)
  • Diffuse large B-cell lymphoma, NOS (not otherwise specified): aggressive
  • Immunoproliferative small intestinal disease (IPSID): malabsorption & Ig (esp. IgA); weight loss + diarrhea (more common in Middle East)
  • Enteropathy-associated T-cell lymphoma (EATCL) : associated to sprue (celiac pt. not responding to gluten-free diet)
  • Post-transplant lymphoproliferative disorder: assoc w/Epstein-Barr -> DEC immunosuppression, and they do much better
33
Q

45-yo AAM w/dyspepsia. No weight loss, fever, or night sweats. Normal PE. Endoscopy and EUS attached.

What should you do next?

A
  • BIOPSY -> this guy had MALT, and was treated for H. pylori
  • Doing well now, and asymptomatic off treatment
  • NOTE: no significant changes on endoscopy, but thickened gastric wall on EUS
34
Q

65-yo w/hx of Hep C. Screening CT attached: gastric tumor w/diffuse perigastric adenopathy and extragastric extension.

What might be going on? Histo?

A
  • MALToma: this is a “bad” one, however, and pt. did not respond to typical tx
    1. Chemo (Rituximab), but pt. ended up with sepsis and multi-organ failure
    2. Dr. T said he gave this example to show that not all MALTomas have a good course
  • HISTO: atypical lymphoid infiltrate (attached)
35
Q

73-yo WM presenting for failure to thrive and abdominal pain. CT of abdomen: wall thickening, multiple periaortic lymph-nodes, multiple liver masses and splenomegaly.

What might this be? Tx?

A
  • Gastric ulcer consistent with diffuse large B-cell lymphoma (DLBCL): started on chemo (R-CHOP)
  • This guy had low Plt, Hct, and WBC, so probably had BM involvement -> died 3 mos after dx
  • VERY aggressive type of tumor
36
Q

What do you see here?

A
  • Diffuse large B-cell lymphoma: worse prognosis (5yr survival 46%)
  • Common histo in gastric lymphoma: 68-75% of GI lymphomas
  • 3% of gastric neoplasms and 10% of lymphomas
  • Age 50-60 years, and male predominance